CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 150 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $205,039 | -22.0% | 6,043 | +2.5% | 0.00% | 0.0% |
| Q4 2022 | $262,785 | -10.3% | 5,896 | -31.7% | 0.00% | 0.0% |
| Q1 2022 | $293,000 | -24.5% | 8,628 | -14.1% | 0.00% | 0.0% |
| Q4 2021 | $388,000 | +22.0% | 10,041 | +70.3% | 0.00% | 0.0% |
| Q3 2021 | $318,000 | -6.5% | 5,895 | -42.0% | 0.00% | 0.0% |
| Q2 2021 | $340,000 | – | 10,171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|